Assenagon Asset Management S.A. Athenex, Inc. Transaction History

Assenagon Asset Management S.A.

  • $54.1 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022
SELL
$1.36 - $2.94 $38,939 - $84,178
-28,632 Closed
0 $0
Q3 2021

Oct 19, 2021
BUY
$2.97 - $4.84 $85,037 - $138,578
28,632 New
28,632 $86,000
Q4 2020

Feb 01, 2021
SELL
$11.06 - $14.01 $6.75 Million - $8.55 Million
-610,067 Closed
0 $0
Q3 2020

Oct 07, 2020
BUY
$10.26 - $14.55 $6.26 Million - $8.88 Million
610,067 New
610,067 $7.38 Million

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email